Drugs Made In America Acquisition (DMII) Net Income towards Common Stockholders (2025)

Drugs Made In America Acquisition (DMII) reported Net Income towards Common Stockholders of $2.3 million for Q4 2025, up 28302.08% quarter-over-quarter from -$8207.0 in Q3 2025.

Drugs Made In America Acquisition (DMII) Net Income towards Common Stockholders (2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has 1 years of Net Income towards Common Stockholders data on file, last reported at $2.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 3.12 Mn
2 Berto Acquisition 312.16 Mn 312.16 Mn - 443,750.00
3 Centurion Acquisition 311.79 Mn 311.79 Mn - 2.02 Mn
4 Churchill Capital Corp IX 309.64 Mn 309.64 Mn - 1.49 Mn
5 WEN Acquisition 308.55 Mn 308.55 Mn - 537,812.00
6 Agriculture & Natural Solutions Acquisition 304.08 Mn 304.08 Mn - -612,993.00
7 Bold Eagle Acquisition 274.25 Mn 274.25 Mn - 382,994.00
8 Soulpower Acquisition 265.17 Mn 265.17 Mn - 2.95 Mn
9 BTC Development 263.21 Mn 263.21 Mn - 1.28 Mn
10 Drugs Made In America Acquisition 129.21 Mn 129.21 Mn - 2.31 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.31 Mn
Sep 30, 2025 -8,207.00